Serum Cytokeratin 18 as a Potential Early Marker for Chemotherapy Response in Breast Cancer Patients: A Prospective Study

BACKGROUND: Currently, it is well recognized that response to neoadjuvant chemotherapy is an important predictive factor for survival in breast cancer patients. However, it is still an area of research about which patient would respond to the neoadjuvant chemotherapy. METHODS: Serum CK18 levels were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendawy, Shimaa R, Mansour, Mostafa, Hamed, Manar, Hossam, Amr, Ramez, Ahmed M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334074/
https://www.ncbi.nlm.nih.gov/pubmed/36974552
http://dx.doi.org/10.31557/APJCP.2023.24.3.969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334074/
https://www.ncbi.nlm.nih.gov/pubmed/36974552
http://dx.doi.org/10.31557/APJCP.2023.24.3.969

Ejemplares similares